These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

224 related items for PubMed ID: 10548074

  • 1. The role of factor XI in coagulation: a matter of revision.
    Minnema MC, Ten Cate H, Hack CE.
    Semin Thromb Hemost; 1999; 25(4):419-28. PubMed ID: 10548074
    [Abstract] [Full Text] [Related]

  • 2. Factor XI dependent and independent activation of thrombin activatable fibrinolysis inhibitor (TAFI) in plasma associated with clot formation.
    Bouma BN, Mosnier LO, Meijers JC, Griffin JH.
    Thromb Haemost; 1999 Dec; 82(6):1703-8. PubMed ID: 10613658
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Factor XI enhances fibrin generation and inhibits fibrinolysis in a coagulation model initiated by surface-coated tissue factor.
    von dem Borne PA, Cox LM, Bouma BN.
    Blood Coagul Fibrinolysis; 2006 Jun; 17(4):251-7. PubMed ID: 16651866
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Plasma TAFI levels influence the clot lysis time in healthy individuals in the presence of an intact intrinsic pathway of coagulation.
    Mosnier LO, von dem Borne PA, Meijers JC, Bouma BN.
    Thromb Haemost; 1998 Nov; 80(5):829-35. PubMed ID: 9843179
    [Abstract] [Full Text] [Related]

  • 7. The defective down regulation of fibrinolysis in haemophilia A can be restored by increasing the TAFI plasma concentration.
    Mosnier LO, Lisman T, van den Berg HM, Nieuwenhuis HK, Meijers JC, Bouma BN.
    Thromb Haemost; 2001 Oct; 86(4):1035-9. PubMed ID: 11686321
    [Abstract] [Full Text] [Related]

  • 8. [Thrombin activatable fibrinolysis inhibitor (TAFI) and its importance in the regulation of fibrinolysis].
    Stasko J, Hudecek J, Kubisz P.
    Vnitr Lek; 2004 Jan; 50(1):36-44. PubMed ID: 15015228
    [Abstract] [Full Text] [Related]

  • 9. Effect of heparin on the activation of factor XI by fibrin-bound thrombin.
    von dem Borne PA, Meijers JC, Bouma BN.
    Thromb Haemost; 1996 Sep; 76(3):347-53. PubMed ID: 8883269
    [Abstract] [Full Text] [Related]

  • 10. Prothrombin is a cofactor for the binding of factor XI to the platelet surface and for platelet-mediated factor XI activation by thrombin.
    Baglia FA, Walsh PN.
    Biochemistry; 1998 Feb 24; 37(8):2271-81. PubMed ID: 9485373
    [Abstract] [Full Text] [Related]

  • 11. The role of factor XI in a dilute thromboplastin assay of extrinsic coagulation pathway.
    He R, Xiong S, He X, Liu F, Han J, Li J, He S.
    Thromb Haemost; 2001 Jun 24; 85(6):1055-9. PubMed ID: 11434684
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Factor XI-dependent reciprocal thrombin generation consolidates blood coagulation when tissue factor is not available.
    Wielders SJ, Béguin S, Hemker HC, Lindhout T.
    Arterioscler Thromb Vasc Biol; 2004 Jun 24; 24(6):1138-42. PubMed ID: 15072993
    [Abstract] [Full Text] [Related]

  • 14. Thrombin, thrombomodulin and TAFI in the molecular link between coagulation and fibrinolysis.
    Nesheim M, Wang W, Boffa M, Nagashima M, Morser J, Bajzar L.
    Thromb Haemost; 1997 Jul 24; 78(1):386-91. PubMed ID: 9198184
    [Abstract] [Full Text] [Related]

  • 15. Regulation of fibrinolysis by thrombin activatable fibrinolysis inhibitor, an unstable carboxypeptidase B that unites the pathways of coagulation and fibrinolysis.
    Mosnier LO, Bouma BN.
    Arterioscler Thromb Vasc Biol; 2006 Nov 24; 26(11):2445-53. PubMed ID: 16960106
    [Abstract] [Full Text] [Related]

  • 16. Roles of platelets and factor XI in the initiation of blood coagulation by thrombin.
    Walsh PN.
    Thromb Haemost; 2001 Jul 24; 86(1):75-82. PubMed ID: 11487044
    [Abstract] [Full Text] [Related]

  • 17. Co-segregation of thrombophilic disorders in factor V Leiden carriers; the contributions of factor VIII, factor XI, thrombin activatable fibrinolysis inhibitor and lipoprotein(a) to the absolute risk of venous thromboembolism.
    Libourel EJ, Bank I, Meinardi JR, Baljé -Volkers CP, Hamulyak K, Middeldorp S, Koopman MM, van Pampus EC, Prins MH, Büller HR, van der Meer J.
    Haematologica; 2002 Oct 24; 87(10):1068-73. PubMed ID: 12368162
    [Abstract] [Full Text] [Related]

  • 18. Increased fibrinolytic activity during use of oral contraceptives is counteracted by an enhanced factor XI-independent down regulation of fibrinolysis: a randomized cross-over study of two low-dose oral contraceptives.
    Meijers JC, Middeldorp S, Tekelenburg W, van den Ende AE, Tans G, Prins MH, Rosing J, Büller HR, Bouma BN.
    Thromb Haemost; 2000 Jul 24; 84(1):9-14. PubMed ID: 10928462
    [Abstract] [Full Text] [Related]

  • 19. Advances and dilemmas in factor XI.
    Gailani D.
    Curr Opin Hematol; 1994 Sep 24; 1(5):347-53. PubMed ID: 9371304
    [Abstract] [Full Text] [Related]

  • 20. The role of protein S in the activation of thrombin activatable fibrinolysis inhibitor (TAFI) and regulation of fibrinolysis.
    Mosnier LO, Meijers JC, Bouma BN.
    Thromb Haemost; 2001 Oct 24; 86(4):1040-6. PubMed ID: 11686322
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.